Report
Martial Descoutures ...
  • Oussema Denguir

BB Biotech AG : Q2 boosted by the recovery in the markets and positive newsflow

>Q2 boosted by rebound in the markets… - This morning BB Biotech reported its Q2 2020 results. The holding company's share price gained 32.9% in euros and 32.1% in Swiss franc over the quarter, reflecting the recovery that began in Q2 as equity markets recovered. The NAV of the portfolio rose by 48.2% in CHF, by 47.7% in euro sand by 51.2% in US dollars, outperforming the reference index the NBI (Nasdaq Biotechnology Index), which rose 26.9% in USD in the period. This...
Underlying
BB Biotech AG

Co.'s principal activity is to invest in biotechnology companies globally. The investments are held through its wholly-owned subsidiaries: Biotech Focus N.V., Biotech Invest N.V., Biotech Target N.V., and Biotech Growth N.V., all of which are located in Curacao. Co. acquires holdings in companies in the biotechnology growth market. The focus of the holdings is on quoted companies that are concentrating on the development and marketing of innovative medicines. For the selection of holdings, Co. relies on fundamental analysis by physicians and molecular biologists.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Martial Descoutures

Oussema Denguir

Other Reports on these Companies
Other Reports from Oddo BHF

ResearchPool Subscriptions

Get the most out of your insights

Get in touch